Spinocerebellar Ataxia Type 7 - Sca7

Spinocerebellar Ataxia Type 7 - Sca7

New study offers hope for patients suffering from a rare form of blindness. A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with far fewer side effects than other medications. Source 3t.